Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Senan

Showing results (181-190 of 348) with videos related to

Pageof 35
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 11, 2013
Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgeryGwendolyn H M J Griffioen, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
Radiation Oncology (London, England)|May 26, 2006
A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancerRené W M Underberg, John R van Sörnsen de Koste, Frank J Lagerwaard, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2007
Four-dimensional computed tomographic analysis of esophageal mobility during normal respirationEdith M T Dieleman, Suresh Senan, Andrew Vincent, et al.
Practical Radiation Oncology|March 29, 2014
Stereotactic ablative radiotherapy: what's in a name?Billy W Loo, Joe Y Chang, Laura A Dawson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 29, 2023
Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapyHilâl Tekatli, Miguel A Palacios, Famke L Schneiders, et al.
Radiation Oncology (London, England)|January 14, 2009
Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL studyCoen W Hurkmans, Johan P Cuijpers, Frank J Lagerwaard, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2009
An evaluation of two internal surrogates for determining the three-dimensional position of peripheral lung tumorsFemke O B Spoelstra, John R van Sörnsen de Koste, Andrew Vincent, et al.
Clinical and Translational Radiation Oncology|October 9, 2023
Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at riskFamke L Schneiders, Claire van Vliet, Nicolas Giraud, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et alCohen W Hurkmans, Johan P Cuijpers, Frank J Lagerwaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2010
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration toolIris E van Dam, John R van Sörnsen de Koste, Gerard G Hanna, et al.
Pageof 35

Showing results (181-190 of 348) with videos related to

Sort By:
Pageof 35
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 11, 2013
Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgeryGwendolyn H M J Griffioen, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
Radiation Oncology (London, England)|May 26, 2006
A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancerRené W M Underberg, John R van Sörnsen de Koste, Frank J Lagerwaard, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2007
Four-dimensional computed tomographic analysis of esophageal mobility during normal respirationEdith M T Dieleman, Suresh Senan, Andrew Vincent, et al.
Practical Radiation Oncology|March 29, 2014
Stereotactic ablative radiotherapy: what's in a name?Billy W Loo, Joe Y Chang, Laura A Dawson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 29, 2023
Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapyHilâl Tekatli, Miguel A Palacios, Famke L Schneiders, et al.
Radiation Oncology (London, England)|January 14, 2009
Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL studyCoen W Hurkmans, Johan P Cuijpers, Frank J Lagerwaard, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2009
An evaluation of two internal surrogates for determining the three-dimensional position of peripheral lung tumorsFemke O B Spoelstra, John R van Sörnsen de Koste, Andrew Vincent, et al.
Clinical and Translational Radiation Oncology|October 9, 2023
Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at riskFamke L Schneiders, Claire van Vliet, Nicolas Giraud, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et alCohen W Hurkmans, Johan P Cuijpers, Frank J Lagerwaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2010
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration toolIris E van Dam, John R van Sörnsen de Koste, Gerard G Hanna, et al.
Pageof 35